Drug giants merge
UK firms Glaxo Wellcome and SmithKline Beecham say they will link up to become the world's biggest drugs group - but warn that job losses will be inevitable.
Glaxo Wellcome: Looking for the next blockbuster
Britain's most profitable pharmaceutical company is desperately in need of a new bestselling drug to repeat the success of its Zantac ulcer treatment.
SmithKline Beecham: From drugs to Lucozade
It's one of the world's leading makers of prescription medicines, but a hefty chunk of its profits comes from non-medical products like toothpaste and nutritional drinks.
The merger's troubled history
The merger of SmithKline Beecham and Glaxo Wellcome has been tried before - and failed after the two chief executives could not agree who would run the new company.